<p>根據 Blue Trust Inc.在最近向證券交易委員會提交的 13F 表格，該公司在第三季度將其在 HCA Healthcare, Inc.（紐約證券交易所代碼：HCA - 免費報告）的持倉降低了 11.1%。該公司在此期間出售了 3,294 股後，持有 26,384 股 HCA 的股票。根據其最近向證券交易委員會的提交，Blue Trust Inc.在 HCA Healthcare 的持股價值為 11,245,000 美元。</p>
<p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
<ul>
<li>MarketBeat 週報 – 07/28 - 08/01</li>
</ul>
<p>其他幾家大型投資者最近也買賣了 HCA 的股票。挪威銀行在第二季度購買了 HCA Healthcare 的新頭寸，價值約為 1,152,408,000 美元。Viking Global Investors LP 在第二季度將其在 HCA Healthcare 的持倉提高了 58.5%。Viking Global Investors LP 現在擁有 1,872,133 股該公司的股票，價值 717,214,000 美元，此前在此期間又購買了 690,773 股。Nordea Investment Management AB 在第二季度將其在 HCA Healthcare 的股份增加了 6.8%。Nordea Investment Management AB 現在擁有 927,781 股該公司的股票，價值 350,404,000 美元，此前又購買了 59,163 股。Pacer Advisors Inc.在第三季度將其在 HCA Healthcare 的持倉提高了 6,115.3%。Pacer Advisors Inc.現在擁有 911,096 股該公司的股票，價值 388,309,000 美元，此前在上個季度又購買了 896,437 股。最後，LSV Asset Management 在第二季度將其在 HCA Healthcare 的股份增加了 0.4%。LSV Asset Management 現在擁有 868,849 股該公司的股票，價值 332,856,000 美元，此前在上個季度又購買了 3,396 股。機構投資者和對沖基金持有該公司 62.73% 的股票。</p>
<h2>分析師評級變動</h2>
<p>一些分析師最近對 HCA 股票發表了看法。Raymond James Financial 在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價設定為 525.00 美元。Oppenheimer 在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 400.00 美元提高到 500.00 美元，並給予該股票 “跑贏大盤” 的評級。Wells Fargo &amp; Company 在 11 月 13 日的研究報告中將 HCA Healthcare 的目標價從 412.00 美元提高到 431.00 美元，並給予該公司 “持平” 的評級。美國銀行在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 430.00 美元提高到 470.00 美元，並給予該股票 “中性” 的評級。最後，Zacks Research 在 11 月 27 日的研究報告中將 HCA Healthcare 的評級從 “強力買入” 下調至 “持有”。十四位股票研究分析師對該股票給予了買入評級，九位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，HCA Healthcare 目前的共識評級為 “適度買入”，共識目標價為 479.00 美元。</p>
<ul>
<li>HCA Healthcare 能否振興市場上最疲軟的行業？</li>
</ul>
<p><strong>閲讀我們關於 HCA 的最新股票報告</strong></p>
<h2>HCA Healthcare 的內部買賣</h2>
<p>在其他新聞中，執行副總裁 Michael R. Mcalevey 在 11 月 5 日的交易中出售了 3,892 股該公司的股票。該股票以 473.79 美元的平均價格出售，總價值為 1,843,990.68 美元。交易後，該執行副總裁直接持有 3,487 股公司股票，價值 1,652,105.73 美元。這筆交易代表了其持倉的 52.74% 的減少。該交易已在向證券交易委員會提交的文件中披露，文件可在此鏈接查看。公司內部人士目前持有 1.30% 的股票。</p>
<h2>HCA Healthcare 交易上漲 0.0%</h2>
<ul>
<li>綜合醫療股票能否在公開市場上成功？</li>
</ul>
<p>HCA 的股票在週五以 474.06 美元開盤。HCA Healthcare, Inc.的 1 年最低價為 289.98 美元，1 年最高價為 520.00 美元。該公司的 50 日移動平均線為 474.62 美元，200 日移動平均線為 419.32 美元。該公司的市值為 1,081.8 億美元，市盈率為 18.32，市盈增長比率為 1.40，貝塔係數為 1.36。</p>
<p>HCA Healthcare（紐約證券交易所代碼：HCA - 獲取免費報告）最近在 10 月 24 日公佈了季度財報。該公司報告本季度每股收益為 6.96 美元，超出分析師的共識預期 5.64 美元，超出幅度為 1.32 美元。HCA Healthcare 的股本回報率為負的 792.25%，淨利潤率為 8.53%。該公司本季度的收入為 191.6 億美元，而分析師的預期為 185.5 億美元。在去年同期，該公司的每股收益為 4.90 美元。與去年同期相比，該公司的收入增長了 9.6%。HCA Healthcare 已將其 2025 財年的指導目標設定為 27.000-28.000 每股收益。平均而言，賣方分析師預測 HCA Healthcare, Inc.在當前年度將發佈 24.98 每股收益。</p>
<h2>HCA Healthcare 宣佈分紅</h2>
<p>該公司最近還披露了一項季度分紅，將於 12 月 29 日支付。12 月 15 日的登記投資者將獲得 0.72 美元的分紅。這相當於每年 2.88 美元的分紅，收益率為 0.6%。除息日期為 12 月 15 日。HCA Healthcare 的分紅支付比率（DPR）目前為 11.13%。</p>
<h2>HCA Healthcare 簡介</h2>
<p>（免費報告）</p>
<p>HCA Healthcare 是一家以盈利為目的的醫療設施運營商，總部位於田納西州納什維爾。該公司成立於 1968 年，擁有並運營一系列醫院和相關醫療設施，並通過有機擴張和收購發展成為大型住院和門診服務提供商。</p>
<p>公司的核心業務包括急性護理醫院、獨立外科和急救中心以及門診診所的運營。HCA 的服務涵蓋住院護理、外科服務、急救醫學、診斷影像和實驗室檢測，以及各種門診和流動護理服務。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們認為比 HCA Healthcare 更好的股票</li>
<li>在 1 月 1 日前投資$1,000 於這隻股票 [不是 NVDA]</li>
<li>將你的 “死錢” 轉變為每月$306+（從這個月開始）</li>
<li>華盛頓準備戰爭</li>
<li>奇怪的水晶金屬性能超過硅達 100 倍</li>
<li>來自奇怪的新 “AI 燃料” 的 33,000% 繁榮？</li>
</ul>
<p><strong>想看看其他對 HCA 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 HCA Healthcare, Inc.（NYSE:HCA - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 於 HCA Healthcare 嗎？</h2>
<p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 HCA Healthcare 並不在名單上。</p>
<p>雖然 HCA Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HCA控股

<p>Blue Trust Inc. 在第三季度減少了對 HCA Healthcare 的持股比例，降幅為 11.1%，目前持有 26,384 股，市值為 1120 萬美元。分析師的評級各不相同，但普遍共識為 “適度買入”，目標價為 479.00 美元。HCA 的股票開盤價為 474.06 美元，過去一年股價區間為 289.98-520.00 美元。該公司報告第三季度每股收益為 6.96 美元，超出預期，收入同比增長 9.6%，達到 191.6 億美元</p>

<p>Blue Trust Inc. lowered its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 26,384 shares of the company's stock after selling 3,294 shares during the period. Blue Trust Inc.'s holdings in HCA Healthcare were worth $11,245,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>根據 Blue Trust Inc.在最近向證券交易委員會提交的 13F 表格，該公司在第三季度將其在 HCA Healthcare, Inc.（紐約證券交易所代碼：HCA - 免費報告）的持倉降低了 11.1%。該公司在此期間出售了 3,294 股後，持有 26,384 股 HCA 的股票。根據其最近向證券交易委員會的提交，Blue Trust Inc.在 HCA Healthcare 的持股價值為 11,245,000 美元。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週報 – 07/28 - 08/01</li>
</ul>
</div><p>Several other large investors also recently bought and sold shares of HCA. Norges Bank purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $1,152,408,000. Viking Global Investors LP raised its position in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after purchasing an additional 690,773 shares during the period. Nordea Investment Management AB increased its stake in HCA Healthcare by 6.8% during the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company's stock worth $350,404,000 after buying an additional 59,163 shares during the period. Pacer Advisors Inc. raised its position in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company's stock valued at $388,309,000 after purchasing an additional 896,437 shares in the last quarter. Finally, LSV Asset Management grew its stake in HCA Healthcare by 0.4% in the second quarter. LSV Asset Management now owns 868,849 shares of the company's stock worth $332,856,000 after purchasing an additional 3,396 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家大型投資者最近也買賣了 HCA 的股票。挪威銀行在第二季度購買了 HCA Healthcare 的新頭寸，價值約為 1,152,408,000 美元。Viking Global Investors LP 在第二季度將其在 HCA Healthcare 的持倉提高了 58.5%。Viking Global Investors LP 現在擁有 1,872,133 股該公司的股票，價值 717,214,000 美元，此前在此期間又購買了 690,773 股。Nordea Investment Management AB 在第二季度將其在 HCA Healthcare 的股份增加了 6.8%。Nordea Investment Management AB 現在擁有 927,781 股該公司的股票，價值 350,404,000 美元，此前又購買了 59,163 股。Pacer Advisors Inc.在第三季度將其在 HCA Healthcare 的持倉提高了 6,115.3%。Pacer Advisors Inc.現在擁有 911,096 股該公司的股票，價值 388,309,000 美元，此前在上個季度又購買了 896,437 股。最後，LSV Asset Management 在第二季度將其在 HCA Healthcare 的股份增加了 0.4%。LSV Asset Management 現在擁有 868,849 股該公司的股票，價值 332,856,000 美元，此前在上個季度又購買了 3,396 股。機構投資者和對沖基金持有該公司 62.73% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>A number of analysts have recently weighed in on HCA shares. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research report on Monday, October 27th. Oppenheimer boosted their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an &#34;outperform&#34; rating in a research report on Monday, October 27th. Wells Fargo &amp; Company raised their target price on HCA Healthcare from $412.00 to $431.00 and gave the company an &#34;equal weight&#34; rating in a research note on Thursday, November 13th. Bank of America lifted their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a &#34;neutral&#34; rating in a research note on Monday, October 27th. Finally, Zacks Research lowered shares of HCA Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, November 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $479.00.</p>
<div class="lb-trans"><p>一些分析師最近對 HCA 股票發表了看法。Raymond James Financial 在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價設定為 525.00 美元。Oppenheimer 在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 400.00 美元提高到 500.00 美元，並給予該股票 “跑贏大盤” 的評級。Wells Fargo &amp; Company 在 11 月 13 日的研究報告中將 HCA Healthcare 的目標價從 412.00 美元提高到 431.00 美元，並給予該公司 “持平” 的評級。美國銀行在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 430.00 美元提高到 470.00 美元，並給予該股票 “中性” 的評級。最後，Zacks Research 在 11 月 27 日的研究報告中將 HCA Healthcare 的評級從 “強力買入” 下調至 “持有”。十四位股票研究分析師對該股票給予了買入評級，九位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，HCA Healthcare 目前的共識評級為 “適度買入”，共識目標價為 479.00 美元。</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否振興市場上最疲軟的行業？</li>
</ul>
</div><p><strong>Read Our Latest Stock Report on HCA</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 HCA 的最新股票報告</strong></p>
</div><h2>Insider Buying and Selling at HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 的內部買賣</h2>
</div><p>In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm's stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新聞中，執行副總裁 Michael R. Mcalevey 在 11 月 5 日的交易中出售了 3,892 股該公司的股票。該股票以 473.79 美元的平均價格出售，總價值為 1,843,990.68 美元。交易後，該執行副總裁直接持有 3,487 股公司股票，價值 1,652,105.73 美元。這筆交易代表了其持倉的 52.74% 的減少。該交易已在向證券交易委員會提交的文件中披露，文件可在此鏈接查看。公司內部人士目前持有 1.30% 的股票。</p>
</div><h2>HCA Healthcare Trading Up 0.0%</h2>
<div class="lb-trans"><h2>HCA Healthcare 交易上漲 0.0%</h2>
</div><ul>
<li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li>
</ul>
<div class="lb-trans"><ul>
<li>綜合醫療股票能否在公開市場上成功？</li>
</ul>
</div><p>Shares of NYSE:HCA opened at $474.06 on Friday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The business's 50 day moving average is $474.62 and its 200-day moving average is $419.32. The firm has a market capitalization of $108.18 billion, a PE ratio of 18.32, a PEG ratio of 1.40 and a beta of 1.36.</p>
<div class="lb-trans"><p>HCA 的股票在週五以 474.06 美元開盤。HCA Healthcare, Inc.的 1 年最低價為 289.98 美元，1 年最高價為 520.00 美元。該公司的 50 日移動平均線為 474.62 美元，200 日移動平均線為 419.32 美元。該公司的市值為 1,081.8 億美元，市盈率為 18.32，市盈增長比率為 1.40，貝塔係數為 1.36。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts' consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analysts' expectations of $18.55 billion. During the same period in the prior year, the business posted $4.90 earnings per share. The business's revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.</p>
<div class="lb-trans"><p>HCA Healthcare（紐約證券交易所代碼：HCA - 獲取免費報告）最近在 10 月 24 日公佈了季度財報。該公司報告本季度每股收益為 6.96 美元，超出分析師的共識預期 5.64 美元，超出幅度為 1.32 美元。HCA Healthcare 的股本回報率為負的 792.25%，淨利潤率為 8.53%。該公司本季度的收入為 191.6 億美元，而分析師的預期為 185.5 億美元。在去年同期，該公司的每股收益為 4.90 美元。與去年同期相比，該公司的收入增長了 9.6%。HCA Healthcare 已將其 2025 財年的指導目標設定為 27.000-28.000 每股收益。平均而言，賣方分析師預測 HCA Healthcare, Inc.在當前年度將發佈 24.98 每股收益。</p>
</div><h2>HCA Healthcare Announces Dividend</h2>
<div class="lb-trans"><h2>HCA Healthcare 宣佈分紅</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.13%.</p>
<div class="lb-trans"><p>該公司最近還披露了一項季度分紅，將於 12 月 29 日支付。12 月 15 日的登記投資者將獲得 0.72 美元的分紅。這相當於每年 2.88 美元的分紅，收益率為 0.6%。除息日期為 12 月 15 日。HCA Healthcare 的分紅支付比率（DPR）目前為 11.13%。</p>
</div><h2>HCA Healthcare Profile</h2>
<div class="lb-trans"><h2>HCA Healthcare 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA Healthcare 是一家以盈利為目的的醫療設施運營商，總部位於田納西州納什維爾。該公司成立於 1968 年，擁有並運營一系列醫院和相關醫療設施，並通過有機擴張和收購發展成為大型住院和門診服務提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>公司的核心業務包括急性護理醫院、獨立外科和急救中心以及門診診所的運營。HCA 的服務涵蓋住院護理、外科服務、急救醫學、診斷影像和實驗室檢測，以及各種門診和流動護理服務。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li>
<li>Washington prepares for war</li>
<li>Strange Crystal Metal Outperforms Silicon Up to 100X</li>
<li>33,000% boom from weird new “AI Fuel?”</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 HCA Healthcare 更好的股票</li>
<li>在 1 月 1 日前投資$1,000 於這隻股票 [不是 NVDA]</li>
<li>將你的 “死錢” 轉變為每月$306+（從這個月開始）</li>
<li>華盛頓準備戰爭</li>
<li>奇怪的水晶金屬性能超過硅達 100 倍</li>
<li>來自奇怪的新 “AI 燃料” 的 33,000% 繁榮？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 HCA 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 HCA Healthcare, Inc.（NYSE:HCA - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 於 HCA Healthcare 嗎？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 HCA Healthcare 並不在名單上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 HCA Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Blue Trust Inc. 減少了其在 HCA Healthcare, Inc. $HCA 的股票持倉